Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

CCL19/MIP-3 beta Mouse anti-Human, Alexa Fluor™ 594, Clone: MM0143-11B4, Novus Biologicals™

Mouse Monoclonal Antibody

Supplier:  Novus Biologicals NBP212097AF594

Catalog No. NP212097A94


Add to cart

Description

Description

CCL19/MIP-3 beta Monoclonal specifically detects CCL19/MIP-3 beta in Human samples. It is validated for Western Blot, Immunohistochemistry, Immunohistochemistry-Paraffin, Immunohistochemistry-Frozen.
Specifications

Specifications

CCL19/MIP-3 beta
Monoclonal
Alexa Fluor 594
50 mM sodium borate with 0.05% sodium azide
CCL19
Human recombinant CCL19/MIP-3 beta
Primary
Human
IgG2
Western Blot, Immunohistochemistry, Immunohistochemistry (Paraffin), Immunohistochemistry (Frozen)
MM0143-11B4
Western Blot, Immunohistochemistry, Immunohistochemistry-Paraffin, Immunohistochemistry-Frozen
beta chemokine exodus-3, Beta-chemokine exodus-3, CC chemokine ligand 19, C-C motif chemokine 19, chemokine (C-C motif) ligand 19, CKb11, EBI1-ligand chemokine, ELCMIP-3-beta, Epstein-Barr virus-induced molecule 1 ligand chemokine, exodus-3, Macrophage inflammatory protein 3 beta, macrophage inflammatory protein 3-beta, MGC34433, MIP-3b, MIP3BCK beta-11, SCYA19EBI1 ligand chemokine, small inducible cytokine subfamily A (Cys-Cys), member 19, Small-inducible cytokine A19
Mouse
0.1 mL
6363
Store at 4°C in the dark.
SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Provide Content Correction

We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Cancel Submit